To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2021

Oral Corticosteroid Improves Walking Ability in Patients with Refractory Lumbar Spinal Stenosis

Vol: 10| Issue: 1| Number:20| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A short-term oral corticosteroid for refractory lumbar spinal stenosis: a double-blinded randomized placebo-controlled clinical trial

Int J Rehabil Res. 2020 Dec;43(4):342-346.

Contributing Authors:
H Akbari Aghdam A Andalib H Asadiyan Ardakani M Telloo E Sheikhbahaei

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-three patients with refractory lumbar spinal stenosis (LSS) were randomized to receive 1 week of oral corticosteroid (prednisolone; n=47) or a placebo (n=46) for the improvement of functionality and relief of pain. The primary outcomes of interest was the improvement in walking distance and Oswestry Disability Index (ODI). The secondary outcomes of interest was pain score on a Numeric Ratin...

Join the Conversation

Please Login or Join to leave comments.